3,7-Dibromodibenzothiophene 5,5-Dioxide>97.0%(GC)200mg

2-Iodo-4-methoxyphenylamine, 98.0%, 25g

2'-(Trifluoromethoxy)-2,2,2-trifluoroacetophenone, 97.0%, 1g

1-METHYL-4-(TRIFLUOROMETHYL)-1H-PYRROLE-3-CARBOXAMIDE, 95.0%, 1g

Tris(4-iodophenyl)amine>97.0%(GC)25g

4-Amino-N-(butylcarbamoyl)benzenesulfonamide, 98%, 1g

3-Ethyl-2-hydroxycyclopent-2-enone, 95.0%, 100g

3-(tert-Butyl)-1-(4-methoxyphenyl)-1H-pyrazol-5-amine, 95.0%, 5g

ethyl 1-(cyanomethyl)-1H-pyrazole-5-carboxylate, 1g

7-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 100mg

4-Nitrophenyl 2-fluoropropanoate, 97%, 1g

2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)5g

1,1,1,3,3,3-esafluoro-2-propanolo (HFIP), 25 ml, >=99%, per la sintesi di peptidi